you mention at the end of your Q that "I am thinking of selling myself as a biostatistician" in the industry in europe. In that case, it would make more sense to read the regulatory guidelines and books about the drug development process, and to sharpen your SAS skills and knowledge of cdisc, sdtm, adam. Large randomised controlled trials tend not to demand sophisticated, complex analyses. A pharma company will want a simple, cogent, unambiguous analysis to persuade the fda after all. They spend $$$ running trials which means issues such as missing data, which can complicate the analysis, are minimised (by data monitoring). There is also a fondness for convention in the industry because convention leads to efficiency (eg re-using sas code and much standardisation). Therefore you'd do better to read a simple book like pocock's book on clinical trials, and if you're ambitious then stephen senn's statistical issues in drug development. That would bring you up to speed. And spend the time you save reading points to consider documents on the EMA website: EMA guidelines